MARÍA JOSÉ
PARELLADA REDONDO
Profesora titular de universidad
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (81)
2024
-
Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis
Psychological Medicine, Vol. 54, Núm. 7, pp. 1339-1349
-
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
Psychiatry Research, Vol. 332
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research, Vol. 267, pp. 534-545
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 243, pp. 32-42
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
-
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure
Human Brain Mapping, Vol. 43, Núm. 1, pp. 37-55
-
Epigenetic clocks in relapse after a first episode of schizophrenia
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity
Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87
-
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden
Schizophrenia Research, Vol. 248, pp. 331-340
-
The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study
Psychiatry Research, Vol. 316
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
-
Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data
Frontiers in Pharmacology, Vol. 12
-
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176